TRIM21 and synovial sarcoma: Of interest, both anti-Ro/SSA positive SS and SS-L patients displayed increased frequency of the A/A genotype compared to HCs (24.1% vs. 10.7%, p = 0.0002, and 26.2% vs. 10.7%, p = 0.002, respectively).